Akt negatively regulates apoptotic pathways at a premitochondrial level through phosphorylation
and modulation of proteins such as Bad, Forkhead proteins, and GSK-3β. Akt has also …

Chemoresistance is a major hurdle for successful cancer therapy. Although multiple
mechanisms have been implicated to be involved in cisplatin resistance, recent evidence has …

Cisplatin-centeredchemotherapy is a key treatment for ovarian cancer, but resistance to
chemotherapeutic agents remains a major cause of treatment failure. Multiple factors are known …

The preantral-early antral follicle transition is the penultimate stage of follicular development
in terms of gonadotropin dependence and follicle destiny (growth versus atresia). Follicular …

Akt is a determinant of cisplatin [cis-diammine-dichloroplatinum (CDDP)] resistance in ovarian
cancer cells, and this may be related to the regulation of p53. Precisely how Akt facilitates …

The inhibitor of apoptosis proteins (IAPs) constitutes a family of highly conserved apoptosis
suppressor proteins that were originally identified in baculoviruses. Although IAP homologs …

… *Address all correspondence and requests for reprints to Benjamin K. Tsang, Ottawa Health
Research Institute, The Ottawa Hospital (Civic Campus), 725 Parkdale Avenue, Ottawa, …

1. Abstract 2. Regulation of follicular development and atresia 3. Regulation of granulosa cell
apoptosis–a physiologic mechanism for ovarian follicular atresia 4. Death pathways in the …

We established previously that X-linked inhibitor of apoptosis protein (Xiap) is a determinant
of cisplatin (CDDP) resistance in human ovarian cancer cells and that down-regulation of …

Resistance to cisplatin‐based chemotherapy is a major cause of treatment failure in human
ovarian cancer. Wild‐type TP53 status is often, but not always, associated with cisplatin …